| Pericardial effusion after streptokinase for acute myocardial infarction: an echocardiographic 1-year follow-up study. | |
| | |
MedLine Citation:
|
PMID: 9397310 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Since the reported incidence of pericardial effusion following thrombolysis is highly variable, we have evaluated 80 consecutive patients with first acute myocardial infarction treated with streptokinase. Two-dimensional echocardiographic studies were performed on days 1, 2, 3, and 7, at 3 and 6 weeks, and 3, 6, and 12 months following acute myocardial infarction. Throughout the study, pericardial effusion was found in 7 of 80 (8.75%) patients, being small in 5 patients, moderate in 1, and large in 1 patient. No clinical, angiographic, or echocardiographic variable was associated with pericardial effusion formation. The incidence of pericardial effusion found in our study is almost three times lower than in other echocardiographic studies on pericardial effusion in thrombolysed patients. Whether this differences results from the beneficial effects of streptokinase is not clear. |
| | |
Authors:
|
P Otasević; A N Nesković; M Bojić; A D Popović |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cardiology Volume: 88 ISSN: 0008-6312 ISO Abbreviation: Cardiology Publication Date: 1997 Nov-Dec |
Date Detail:
|
Created Date: 1998-01-16 Completed Date: 1998-01-16 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 1266406 Medline TA: Cardiology Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 544-7 Citation Subset: IM |
Affiliation:
|
Cardiovascular Research Center, Dedinje Cardiovascular Institute, Belgrade, Yugoslavia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Flow Velocity Cardiac Volume Coronary Angiography Echocardiography, Doppler* Electrocardiography Female Fibrinolytic Agents / administration & dosage, adverse effects*, therapeutic use Follow-Up Studies Humans Infusions, Intravenous Male Middle Aged Myocardial Contraction Myocardial Infarction / drug therapy* Pericardial Effusion / chemically induced*, ultrasonography Prospective Studies Streptokinase / administration & dosage, adverse effects*, therapeutic use Stroke Volume Thrombolytic Therapy / adverse effects* |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; EC 3.4.-/Streptokinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical significance of the urinary oxygen tension in patients with ischemic heart disease.
Next Document: Early administration of ramipril in acute myocardial infarction: neurohormonal and hemodynamic effec...